The largest database of trusted experimental protocols

Vimentin v9

Manufactured by Agilent Technologies
Sourced in Denmark, United States

Vimentin (V9) is a mouse monoclonal antibody that recognizes the intermediate filament protein vimentin. Vimentin is a structural protein found in the cytoplasm of various cell types and is commonly used as a marker for mesenchymal cells. The V9 clone is a well-characterized antibody for the detection of vimentin expression in research applications.

Automatically generated - may contain errors

9 protocols using vimentin v9

1

Comprehensive Immunohistochemical Analysis of NMC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Available tissue sections were used for immunohistochemistry (IHC) analyses of these 5 NMC cases. Surgical tissue sections were sectioned at 4 μm thickness and then stained with primary antibodies specific for NUT (ab122649, 1 : 500, Abcam, UK), CK (AE1/AE3, prediluted; Dako, Denmark), vimentin (V9, prediluted; Dako), CK7 (EP16, 1 : 200, ZSGB‐BIO, China), SMA (1A4, 1 : 200, ZSGB-BIO), CD34 (QBEND, prediluted, Dako), p63 (ZM-0406, prediluted, ZSGB‐BIO), p40 (ZA-0483, 1 : 100, ZSGB‐BIO), Syn (DAK-SYNAP, prediluted, Dako), CD56 (123C3, prediluted, Dako), CgA (DAK-A3, prediluted, Dako), and Ki-67 (MIB-1, prediluted, Dako). A Dako Omnis automated staining platform was used for the IHC staining of these formalin-fixed paraffin-embedded whole tissue sections. Appropriate positive controls were used for all assays.
+ Open protocol
+ Expand
2

Immunohistochemical Analysis of Mouse and Human Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissues collected from mice or patients were fixed overnight in buffered formalin (Fisher Scientific, #23-011-120) and processed in the tissue core facility at Mayo Clinic, AZ. Deparaffinized and rehydrated 5–6 μm sections were unmasked for 15 min in EDTA Buffer (1mM EDTA, 0.05% Tween 20, pH 8.0) at 95–99°C. Primary antibodies purchased from Life Technologies (pan-cytokeratin clone AE1/AE3 at 1:300 and Vimentin V9 at 1:2000) and Dako North America (Ki67 clone MIB1 at 1:600, CD45 clone 2B11+PD7/26 at 1:500) were incubated overnight at 4°C. Secondary antibody (Cell Signaling, SignalStain Boost IHC detection system #8125S) was applied for 30–60 min at room temperature. Chromogenic detection of protein expression was determined in the presence of DAB (BioCare, Betazoid DAB) and visualized by light microscopy.
+ Open protocol
+ Expand
3

Comprehensive Immunohistochemical Analysis of Tissue Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three‐micrometer‐thick tissue sections were cut and stained with hematoxylin‐eosin or periodic acid–methenamine silver (PAM). Immunohistochemical staining was performed on FFPE tissue sections. Primary antibodies against the following antigens were applied: vimentin (V9; 1:200; Dako, Glostrup, Denmark), glial fibrillary acidic protein (GFAP) (1:5000) (15 (link)), Olig2 (1:5000) (16 (link)), cytokeratin (CAM5.2; 1:5; BD Bioscience, San Jose, CA, USA), α‐smooth muscle actin (αSMA) (1A4; 1:3200; BioMakor, Rehovot, Israel), epithelial membrane antigen (EMA) (E29; 1:100; Dako), synaptophysin (27G12; 1:200; Novocastra, Newcastle upon Tyne, UK), NeuN (A60; 1:1000; Chemicon, Temecula, CA, USA), podoplanin (D2‐40; prediluted; Nichirei, Tokyo, Japan), CD99 (12E7; 1:50; Dako), L1CAM (UJ127; 1:100; Novus Biologicals, Littleton, CO, USA), p65/RelA (D14E12; 1:400; Cell Signaling Technology, Danvers, MA, USA), BAF47/INI1 (BAF47; 1:100; BD Bioscience, San Jose, CA, USA), BRG1 (polyclonal; 1:1000; Millipore, Temecula, CA, USA), and Ki‐67 (MIB‐1; 1:100; Dako). For coloration, a commercially available biotin‐streptavidin immunoperoxidase kit (Histofine, Nichirei) and diaminobenzidine were employed.
+ Open protocol
+ Expand
4

Immunohistochemical Profiling of FFPE Tumor Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumour tissue and the agarose-embedded close-to-patient cancer cells were formalin fixed and paraffin embedded (FFPE) before 4 μm sections were cut for both H&E and immunohistochemistry (IHC) analysis. IHC was performed using standard techniques and in line with the manufacturer's instructions for the following primary antibodies: Cytokeratin (MNF116, DAKO), EpCam (Ber-EP4, DAKO), CD44 (DF1485, DAKO), p53 (DO-7, DAKO), Vimentin (V9, DAKO), TFF3 (Abcam), and ALDH1A1 (EP1933Y, Abcam) (see online supplementary method S6). Sections were viewed with a Leica DMLB Bright-field Microscope (Leica-microsystems, Milton Keynes, UK) and images acquired with Leica QWin Standard v3 software. The presence of any characteristically stained cells was considered positive with respect to negative controls, and confirmed by a second blinded individual.
+ Open protocol
+ Expand
5

Immunohistochemical Staining Procedures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Staining procedures were performed as previously described [55 (link)]. For human vimentin (VimentinV9, M0725, Dako, 1:1000) and cleaved caspase-3 staining (ASP175, Cell Signaling Tech, 1:400), heat-induced epitope retrieval was performed by microwave boiling for 15 min in TE (Tris/EDTA, pH 9) buffer (Dako). Collagen staining was performed using Sirius Red stain and analyzed by polarized light microscopy.
+ Open protocol
+ Expand
6

Immunohistochemical Staining of Mouse Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Subcutaneous nodules on mouse backs were fixed in 20% formalin and embedded in paraffin. Cut paraffin sections were deparaffinized, dehydrated, and treated with 2% proteinase K (Dako) in Tris–HCl buffer solution (pH 7.5) for 5 min at room temperature, or heated in ChemMate Target Retried Solution (Dako) for 5–20 min in a high-pressure steam sterilizer for epitope unmasking. After washing with distilled water, samples were placed in 1% hydrogen peroxide/methanol for 15 min to block endogenous peroxidase. The sections were then incubated at room temperature for 60 min in primary antibodies diluted with antibody diluent (Dako). The following primary antibodies against various human differentiation antigens were used: vimentin (V9, M0725, Dako, Glostrup, Denmark), albumin (Dako), AE1/AE3 (712811, NICHIREI), and Ki67 (ABCAM, ab15580). Then, they were washed three times with 0.01 M Tris buffered saline (TBS) solution (pH 7.4) and incubated with goat anti-mouse or anti-rabbit immunoglobulin labeled with dextran molecules and horseradish peroxidase (EnVision, Dako) at room temperature for 30 min. After three times washes with TBS, they were incubated in 3,3′-diaminobenzidine in substrate-chromogen solution (Dako) for 5–10 min. Negative controls were performed by omitting the primary antibody. The sections were counterstained with hematoxylin.
+ Open protocol
+ Expand
7

Histopathological and Ultrastructural Analysis of CAPNON

Check if the same lab product or an alternative is used in the 5 most similar protocols
The surgical resection or biopsy specimens were formalin fixed, routinely processed, paraffin-embedded, sectioned at 5 μm, and stained with hematoxylin and eosin (H&E) and by IHC. The H&E-stained slides were examined for histopathological features. Automated IHC was performed on tissue sections using the Dako Autostainer Link 48 and visualized with the Dako Envision Flex kit detection system (Dako, Carpinteria, CA, USA). Antibodies to the following were used: Neurofilament-light (NF-L; 2F11, Dako), Neurofilament-phosphorylated (NF-p; SMI 31, Covance, Berkeley, CA, USA), CD68 (KP1, Dako), CD8 (C8/144B, Dako), CD4 (4B12, Dako), glial fibrillary acidic protein (Z0334, Dako), Vimentin (V9, Dako), Desmin (D33, Dako), epithelial membrane antigen (E29, Dako), and synaptophysin (27G12, Leica). The antibodies listed here were only those immunostains described later in this study, while a few other immunostains and histological stains were also performed for the diagnosis of CAPNON in most cases. 3, 4 Electron Microscopy
In three selected cases of CAPNONs, a small portion of the tissue was fixed in 2% glutaraldehyde, postfixed in 1% osmium tetroxide, dehydrated, and embedded in resin. Ultrathin sections were stained with uranyl acetate followed by lead citrate and examined with JEOL 1230 Transmission electron microscope (EM).
+ Open protocol
+ Expand
8

Comprehensive Immunohistochemical Analysis of Tissue Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
The biopsy specimen was fixed in buffered formalin and embedded in paraffin for routine histological examination. Immunohistochemical studies were performed on 3-µm sections cut from paraffin blocks using a fully automated system ("Benchmark XT System", Ventana Medical Systems Inc., 1910 Innovation Park Drive, Tucson, Arizona, USA) and the following antibodies: pan cytokeratin (clone AE1/AE3, 1 : 40, Zytomed, Berlin, Germany), vimentin (V9, 1 : 100, Dako, Hamburg, Germany), CK7 (clone OV-TL, 1 : 1000, Biogenex), CK18 (clone CY-90, 1 : 500, Sigma), CK5 (clone XM26, 1 : 50, Zytomed), TTF-1 (clone 8G7G3/1, dilution, 1 : 500, Zytomed), ERG (clone EPR3864, prediluted/ ready to use, Ventana Medical Systems), CD31 (clone JC70A, 1 : 20, Dako), CD10 (clone 56C6, 1 : 20, Dako), p63 (clone SFI-6, 1 : 100, DCS), desmin (clone D33, 1 : 250, Dako), α-smooth muscle actin (clone 1A4, 1 : 200, Dako), S100 protein (polyclonal, 1 : 2500, Dako), CD34 (clone BI-3C5, 1 : 200, Zytomed), CD30 (clone Ber-H2, 1 : 40, Zytomed), MUC4 (clone EP256, 1:500, Epitomics), TLE1 (polyclonal, 1 : 200, Santa Cruz), STAT6 (clone sc-621, 1 : 1000, Santa Cruz Biotechnology), and SMARCB1 (INI1) (MRQ-27, 1 : 50, Zytomed), according to the manufacturer instructions.
+ Open protocol
+ Expand
9

Immunohistochemical Profiling of Tumor Specimens

Check if the same lab product or an alternative is used in the 5 most similar protocols
All tumour specimens had been fixed in buffered formalin overnight and processed routinely for histological assessment. Immunohistochemistry, on 3 μm sections cut from paraffin blocks, was performed using a fully automated Benchmark XT System (Ventana Medical Systems, Tucson, AR, USA) and the following antibodies: pan-cytokeratin (clone AE1/AE3, 1:40, Zytomed); CK7 (OV-TL, 1:1000, Biogenex); vimentin (V9, 1:100, Dako); desmin (clone D33, 1:250, Dako); α-smooth muscle actin (clone 1A4, 1:200, Dako); h-caldesmon (clone h-CD, 1:100, Dako); protein S-100 (polyclonal, 1:2500, Dako); CD34 (clone BI-3C5, 1:200, Zytomed); ERG (EPR3864, prediluted, Ventana); myogenin (clone F5D, 1:50, Dako); and STAT6 (clone sc-621, 1:1000, Santa Cruz Biotechnology, Santa Cruz, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!